GeneDx Holdings WGS Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $427.54M+40.0% | $305.45M+50.8% | $202.57M-13.7% | $234.69M+10.6% | ||
| $129.37M+16.5% | $111.05M-1.3% | $112.56M-56.9% | $261.44M+14.3% | ||
| $298.17M+53.4% | $194.4M+116% | $90.01M+436% | -$26.75M-61.1% | ||
| 69.7%+6.1pp | 63.6%+19.2pp | 44.4%+55.8pp | -11.4%-3.6pp | ||
| $72.03M+57.5% | $45.72M-21.5% | $58.27M-32.4% | $86.2M-18.0% | ||
| —— | —— | —— | —— | ||
| —— | $0-100% | $10.4M-95.1% | $210.15M— | ||
| -$2.54M+16.3% | -$3.03M— | —— | $3.21M+13.1% | ||
| -$8.06M+72.6% | -$29.42M— | —— | $69.62M-65.3% | ||
| —— | —— | —— | $0+100% | ||
| -$21.02M— | —— | -$175.77M+68.0% | -$548.98M-124% | ||
| -4.9%— | —— | -86.8%+147pp | -233.9%-118pp | ||
| -$0.73— | —— | -$7.44+86.3% | -$54.45— | ||
| 115.3M+8.1% | 106.7M+11.6% | 95.6M+142% | 39.4M-87.7% | ||
| 114.2M+7.0% | 106.7M+11.6% | 95.6M+142% | 39.4M-86.7% | ||
| -$2.54M+16.3% | -$3.03M— | —— | —— | ||
| —— | -$13.37M-1,243% | $1.17M— | —— | ||
| -$20.92M— | —— | -$175.34M+68.1% | -$548.98M-124% | ||
| $48.03M+8.7% | $44.16M-76.4% | $187.15M-5.5% | $197.96M-60.0% | ||
| -$61.52M-104% | -$30.13M+31.1% | -$43.73M+69.1% | -$141.33M-580% | ||
| $36.37M+228% | -$28.5M+84.2% | -$180.15M+43.6% | -$319.16M-158% | ||
| —— | —— | $425K— | $0— | ||
| $427.54M+40.0% | $305.45M+50.8% | $202.57M-13.7% | $234.69M+10.6% | ||
| $12.15M— | —— | -$146.86M+75.9% | -$608.34M-228% | ||
| 2.8%— | —— | -72.5%+187pp | -259.2%-172pp | ||
| -$13.08M— | —— | -$180.6M+73.0% | -$667.65M-222% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is GeneDx Holdings's revenue?
- GeneDx Holdings (WGS) generated $442.7M in revenue over the trailing twelve months, up 34.1% year over year.
- Is GeneDx Holdings profitable?
- GeneDx Holdings is not currently profitable: it reported a net loss of $77.8M over the trailing twelve months, a -17.6% net margin.
- What are GeneDx Holdings's profit margins?
- Gross margin is 69.6% and operating margin is -14.9%, with a -17.6% net margin.
- What is GeneDx Holdings's earnings per share?
- GeneDx Holdings's diluted EPS over the trailing twelve months is $-2.68.
- Where does GeneDx Holdings's income statement data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
